Investors in CVS Health Corp. (NYSE: CVS) will be looking for signs of improvement when the company's fourth-quarter and full-year earnings are released Wednesday morning ahead of the opening bell.
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for prescription drugs.
Express Scripts sued the FTC in September, alleging its first report was defamatory and unconstitutional. The FTC's findings focus on "cherry-picked 'specialty generic' outliers," a CVS Caremark ...
In the lawsuit, AG Gentner Drummond outlined 200 individual prescription claims that were reimbursed below acquisition cost ...
Attorney General Gentner Drummond sued CVS Caremark in an Oklahoma administrative court alleging that the company is under ...
Hosted on MSN9mon
CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?CVS Health Corporation CVS is scheduled to report first-quarter 2024 results ... Following a highly successful 2024 annual enrollment period, CVS expects to add at least 800,000 new members ...
PBM-affiliated pharmacy dispensing revenue increased at an annual growth rate of ... did not allow them to preview the report. “Our clients, not CVS Caremark, select which specialty and non ...
Attorney General Gentner Drummond sued CVS Caremark Tuesday in an Oklahoma administrative court alleging that the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback